Clinical Trial Update: PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Histology [Phase 1]

View source ↗

Summary

Phase 1 trial update showing biological effects of PEP005 Gel in actinic keratosis as assessed by histology; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• PEP005 Gel (ingenol mebutate)

Snippet

Sponsor: LEO Pharma | Conditions: Actinic Keratosis | Phase 1 | Status: COMPLETED